NCT00001676View on ClinicalTrials.gov

Cyclophosphamide and Fludarabine to Treat Lupus Nephritis

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 31, 1998

Study Completion Date

November 30, 2002

Conditions
GlomerulonephritisLupus NephritisSystemic Lupus Erythematosus
Interventions
DRUG

SQ Fludarabine

Trial Locations (1)

20892

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda

All Listed Sponsors
lead

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

NCT00001676 - Cyclophosphamide and Fludarabine to Treat Lupus Nephritis | Biotech Hunter | Biotech Hunter